Erratum to ‘Primary versus interval cytoreductive surgery in patients with rare epithelial or non-epithelial ovarian cancer’ [International Journal of Gynecological Cancer Volume 35 Issue 3 (2025) 101664] (International Journal of Gynecological Cancer (2025) 35(3), (S1048891X25001896), (10.1016/j.ijgc.2025.101664))

In the original published version of this article, the following errors were introduced during the copyediting process by the Suppliers. The text originally published “Furthermore, the results following neoadjuvant chemotherapy in non-epithelial ovarian cancers, such as ovarian germ cell tumors, sex-cord stromal tumors, and small-cell carcinoma of the ovary, have also been reported.” Has been corrected to “Further, results following neoadjuvant chemotherapy in non-epithelial ovarian cancer, such as ovarian germ cell tumors, sex-cord stromal tumors, and small cell carcinoma of the ovary, hypercalcemic type were also reported." The text originally published “Despite several limitations, including their retrospective design and potential selection bias, these studies highlight that non-high-grade serous ovarian carcinomas have distinct biological behaviors from their high-grade serous counterparts.” Has been corrected to “These studies, despite several limitations including their retrospective design and potential selection bias, highlight that non-high-grade-serous epithelial carcinomas of the ovary have a distinct biological behavior from their high-grade serous counterpart." The text originally published “One-fourth of endometriotic cysts arise from mutations in genes such as ARID-1a.” Has been corrected to “One fourth arise in endometriotic cysts and via mutations of genes such as ARID-1a.” The text originally published “No prospective randomized trial has focused on the use of neoadjuvant chemotherapy and cytoreductive surgery versus primary cytoreductive surgery for mucinous ovarian cancer.” Has been corrected to “No prospective randomized trials focus on the use of neoadjuvant chemotherapy and interval cytoreductive versus primary cytoreductive surgery in mucinous ovarian cancer.” The text originally published “Van Wagensveld and colleagues compared patients with mucinous ovarian cancer to those with other epithelial histotypes receiving neoadjuvant chemotherapy.” Has been corrected to “When comparing patients with mucinous ovarian cancer and patients with other epithelial histotypes receiving neoadjuvant chemotherapy, Van Wagensveld et al. indicated similar outcomes between the groups.” These errors bear no reflection on the article or its authors. The publisher apologizes to the authors and the readers for this unfortunate error.